This paper reviews a personal experience of 51 cases seen over a 30 year period. Patients were treated in either a combined Head and Neck clinic or a Combined Ophthalmology clinic and a balanced view is thus represented. A method of grading the severity of the disease is described as well as a method of assessing response. This approach has not been proposed hitherto. It is generally concluded that the preferred treatment for small lesions is excisional surgery and for larger lesions carefully planned and highly localized radiation.
Introduction
Cavernous haemangioma in infants usually runs a self-limiting, but dramatic course. On the other hand, those seeking help in adult life have disease which although commencing in childhood, is usually static but often produces great deformity and distress. There are many reports of the treatment of this condition, often based upon small series of patients. The diversity of treatments advocated which include steroids', pressure2, major surgery3-6, cautery, embo-lization7'8, intra-arterial cytotoxic drugs9"10, sclerosing agents'1, laser beam therapy, cryotherapy'2, and radiation, is testimony to the poor results often obtained. It is the purpose of this paper to review 51 cases seen over a 30 year period in the Combined Head and Neck clinic and the Combined Ophthalmology clinic at this hospital and to provide information on radiotherapeutic techniques and a dose-response curve to enable reliable treatment to be given. This is especially relevant to those patients with the grosser forms of the disease, and of interest because it is derived from a non-cancerous tissue.
To evaluate the severity of the condition an arbitrary grading method has been devised ( Table 1 ).
Patients and methods
Fifty-one patients (30 males and 21 females) were seen from 1955 to 1987. The mean age at presentation was 37.8 years and the mean age of onset was 20.7 years. The age of onset was earlier with grade HI disease (6.7 years) and for females (11.8 years) than males (27.7 years) . The disease was assigned to three anatomical regions and graded ( Table 1 ). The commonest symptoms were bleeding (22) and a mass (14) , whilst increase in the size of a mass often caused the patient to seek advice. However, serious symptoms were bleeding needing blood replacement (1), proptosis (10), with rapid visual deterioration (4), dysphagia (3), and respiratory obstruction (2) . Severe pain was a feature in two patients with large orbital lesions, both of which came to exenteration. (1) , and hypoplasia of the jaw associated with the lesion (4) . CAT scans were helpful in delineating the lesion in the 6 patients with orbital disease. Four patients with grade m lesions had Figure 1 . The principle ofvisual pathway shielding (250 kV) for benign lesions is shown. Note there is no normal tissue margin round the lesion and that the dose would be below optic nerve tolerance. The lacrimal gland is shielded angiography which demonstrated the lesions well but did not contribute to management. Thirty-three patients had histological confirnation of the disease.
Previous treatment
Sixteen patients (32%) had had treatment before being seen. Two ofthese had grade I lesions, 3 grade II, and 11 grade III. Fourteen patients had undergone a total of 30 attempted excisions, 4 patients a total of 8 diathermy treatments, 4 patients had received steroids and 2 embolization. Nevertheless, all patients had florid disease with no evidence that these treatments had affected the disease.
Treatment policy
All patients were seen in the Combined Head and Neck clinic which consists of plastic surgeons, radiotherapists and dentists (and formerly general surgeons and otorhinolaryngologists) or the Combined Ophthalmology clinic which is staffed by ophthalmologists and radiotherapists. All patients were seen by the principal author.
Treatment
Nine patients received no treatment. One lesion regressed after biopsy and one other after parturition. In 3 patients the disease was asymptomatic. One refused further treatment, one had had 5 attempts at excision before being seen and the viability of remaining tissue was in doubt, and 2 patients had disease not amenable to surgery but were seen before irradiation was freely offered. The course ofthis group of patients is of interest; one ofthese patients was lost to follow-up, 3 lesions partially regressed and 5 remained unchanged for periods of 12-36 months. The mean follow-up time for this group was 14.5 months (range 0-36). The rest of the patients received treatment. For grade I disease simple surgical excision was offered and was effective, except in two cases (2/13). In grade II disease one of 4 patients had persisting disease after surgery, and one of 3 radiation treatments failed. Irradiation was favoured for grade III disease (15 patients). Two patients received large doses of steroids without benefit. Two patients had their lesions embolized, without lasting effect and in one patient a second embolization was followed by extensive tissue necrosis. The choice of treatment modality was little affected by the site of lesion.
Radiation techniques
There are important differences in curatively irradiating these lesions from those used in cancer treatment. Firstly, no margin of normal tissue round the lesion need be treated. Secondly, since the dose delivered to the lesion is lower than that used in cancer therapy a greater inhomogeneity of dose is acceptableto about 20%. Thirdly scrupulous attention must be given to avoiding sensitive normal structures, such as the visual pathway, lachrymal and salivary glands, and the jaw. Complex screening is not possible with supervoltage X-rays, but is easily achieved with heavily filtered deep X-ray therapy (250 kV 3.5 mm Cu half value layer) where 2 mm of lead will attenuate the beam by 90%. Two examples are anterior visual pathway shielding for benign orbital lesions ( Figure 1 ) and jaw shielding for lingual lesions using individually made lead shields which confine the radiation to the lesion (Figure 2 ).
Radiation dosage
Fear oflate radiation effects has led to the use ofsmall doses. This was the case with the earlier patients in this series. However, Figure 3 shows that the lower doses used were without exception ineffective and those in the middle range were followed by only a partial improvement in the disease or relapse. On the other hand, higher doses were without exception followed by resolution which took place over a few weeks to about 18 months. The required dose is within tolerance of all but the most sensitive structures. The ideal lesion dose is probably a time dose fraction (TDF)13 of 65-70 delivered in 6 equal fractions, 3 times per week, over 12 days. Multiple treatments Primary treatment failures were seen after 4 excisions, 5 radiotherapy treatments, 2 courses of steroids and one embolization. Twelve patients, therefore, received multiple treatments in our hands, most had grade m disease (8/12) or C involvement (8/12). Seven received 2 treatments, 2 patients received 3, and 3 patients received 4 treatments. The subsequeont treatments were evenly divided between surgery (10) and radiotherapy (8) . Two of the subsequent surgical treatments involved exenteration of the orbit, one of which was followed by progression of; persisting disease and which finally yielded to 50.00 Gy in 25 fractions.
Case reports
Case 1: Presented at the age of.13 with gross haemangioma of the whole .1ongue since birth. The major complaints were pain, bleeding, dysphagia and respiratory obstruction. Previous treatments incluied partial excision twice, cautery five times, prednisolone and tri&heotomy. The patient had spent most of his life in hospital and was on continuous iron medication for bleeding. A lesion dose of 23.00 Gy in 6 fractions in 12 days (250 kV 3.5 cu half valve Iayer (HVL)) was given using palatal and jaw shielding, with regression of most of the lesion within 3 months. Four years later there was no bleeding and no discomfort. The patient had gained 25 kg, grown 30 cm, had orthodontic treatment without complications and was leading a normal life.
Case 2: Aged 65, this patient had sleep apnoea for whole life because of haemangioma of the palate, which had recently increased in size and was causing dysphagia and dyspnoea on exertion. Tracheotomy had been advised. There was a massive lesion ofthe soft palate, left post-nasal space and fauces. A highly localized lesion dose of 36.00 Gy in 12 fractions in 36 days (Cobalt 60) was given. Two years later there was complete relief of symptoms and regression ofthe mass.
Case 3: Aged 28. A purple mass had been present in the whole cheek since birth. Three attempts at excision at 4, 20 and 21 years of age had been followed by persisting disease. A further excision on presentation was followed by an illdefined recurrence 4 years later. A moderate dose radiation 19.80 Gy in 6 fractions in 12 days (250 kV 3.5 cu HVL) caused no change in the mass at 7 months. The dispirited patient declined hospital attendance.
Case4: Aged 13. A 30 mm lesion had been present on the lower lip since birth. Low dose radiation (because of age) 15.00 Gy in 15 fractions in 21 days (250 kV 3.5 cu HVL) did not affect the disease. An excision wgs performed with no recurrence' after 3 years follow-up.
Final results of treatment
The follow-up times in this series, were long and ranged from 0 to 252 months for the surgical treatments (mean 49.4) and from 7 to 360 months for the radiotherapy treatments (mean 74.6). Thirty-six patients were followed up for more than 12 months. Ten of 11 patients with grade I lesions who received surgical treatment remained well. Two of 5 patients had persisting disease after surgery for grade II disease, whilst one patient with grade II disease had complete regression after radiation. Both patients with grade IIH disease failed after surgery, whilst 2 of 16 patients with grade m disease treated with irradiation failed.
Complications and late effects One patient (Site A+B+C grade III) bled severely at attempted excision which -had to be abandoned, one has limitation of downward gaze with diplopia after orbital surgery, and another with an orbital lesion experienced a fall in visual acuity. One patient experienced mental changes on steroids and one an extensive cheek and lip necrosis after embolization. No marked late effects have been seen after irradiation, but two patients with orbital disease have tiny stationary posterior polar opacities. Two have moderate orbital fat atrophy. Vision is unchanged in two patients, decreased by one line in one patient (to 6/7.5), and improved in 4 (to 6/12, 6/18, 6/18 and 6/24). One young patient who had low dose irradiation and exenteration of the orbit, became mentally disturbed. Discussion This is the first series of patients reported by a multidisciplinary group and represents a balanced view. Moreover follow-up times are long allowing for the observation of failures and late effects of treatment. The proposed grading is an arbitrary one but it provides a basis of intercomparison which has not existed hitherto, laying the basis for an approach to treatment. The regional siting also provides a classification for comparative purposes. Further, the assessment of response to treatment used here (Figure 3) as complete, partial (over 50% regression), recurrence after partial or apparent complete response, and no response also provides a basis for intercomparison. These are not features of other publications but are essential for the assessment of the many and varied treatments offered in the literature. The most common presenting symptom was bleeding, especially in site B patients, whereas swelling or increase in size of a swelling was found in all three areas and grades. Respiratory distress was a major problem to both patients presenting with dyspnoea. Proptosis was the most common orbital symptom, often associated with a rather sudden and rapid fall in visual acuity. Orbital lesions, therefore, require prompt therapy. Our experience with treatment confirms the views of others that simple excision of small lesions is effective and is the treatment of choice. Persistence or recurrence is common after surgery for larger lesions6,12"14 which is similar to our experience and also that of others at other sites'5. Excision is not without hazard'4 and there was one near fatality in this series. On the other hand larger lesions were irradiated with gradually increasing doses and with increasing effect.
In spite of the relatively long periods of follow-up in this series, no deleterious late effects of radiation have been seen and, in particular, no malignant change observed. It has been stated16 that in infants radiation should be used only very rarely and when other methods of treatment had been carefully considered. We support this view. Young children with major deforming disease should be examined periodically and treated by other means until near adult life when radiation as described is one of the options to be considered. The situation is different where those nearing adult life, or adults, suffer from a serious malformation. There are some claims about the great effectiveness of adequate radiation treatment17 but little information on adult dose levels. Hope-Stone'8 advocates a higher dose for spinal lesions than that used here, whilst a case report'9 claims complete cure with the same TDF advocated by us. A number of assertions have been made about the inadequacy of irradiation3 but without treatment details. A similar situation applies to those reporting high dose effects. Malignancy has been reported following irradiation2°but associated with high doses to childhood lesions'7. Moreover, a haemangioma may be the seat of malignant change without exposure to radiation22. In this sres we have had no exFperience of intra-arerial chemotherapy'023 but this treatment does not seem to be associated with complete remission and in our experience may be hazardous24. Nor do we have experience of sclerosants, but these also may be associated with complications25. Compression therapy may offer an incomplete response2 '9 whilst the response to cryotherapy may be good, possibly for smaller or inter-mediate lesions12. All 6 patients in this series who received steroid therapy did not benefit. This corresponds with the experience of others27. Four patients had their lesions embolized without benefit, whilst one of these patients experienced a major necrosis. Others have found embolization unsatisfactory with sloughing ofthe embolized area and loss of vision28. Embolization may be incomplete even when combined with ligation7. Super-selective embolization has only resulted in partial responses29. It has recently been stated that the embolization of cavernous malformations is disappointing30.
Two patients in this series had progression of their haemangiomas associated with pregnancy and a cautious approach seems warranted in the postpartum patient since the disease may regress spontaneously.
Major orbital haemangoma is a formidable condition and in this series inadequate surgery and low dose radiation was followed by thrombosis, blindness and pain, necessitating exenteration in two cases. On the other hand, radiation as described was uniformly effective in 7 cases without late sequelae. It would thus appear to be the treatment of choice in grades II and IH disease in this site. Lastly, it is concluded that the major head and neck cavemous haemangioma should be treated by a small group of persons who have long-term continuing experience.
